Profitable Telemedicine Company Investment Opportunity in Sydney, Australia
Established | 5-10 year(s) |
Employees | 10 - 50 |
Legal Entity | Private Limited Company |
Reported Sales | USD 110 thousand |
Run Rate Sales | USD 150 thousand |
EBITDA Margin | 27 % |
Industries | Telemedicine |
Locations | Sydney + 1 more |
Local Time | 11:27 PM Asia / Kuala Lumpur |
Listed By | Advisor / Business Broker |
Status | Active |
The company addresses a global telehealth market size that is expected to reach US9.35 billion by the end of this year with an impressive 32.5 % annual growth rate. The company is an active service provider in the Ukrainian crisis displaying exceptional healthcare services.
Business is registered in Australia with a branch in Singapore but employees work remotely.
Business is listed by an advisory company based in Malaysia.
Key Metrics:
- AUD 1.7 million platform turnover.
- 18k+ consultation sessions.
- Zero debt and zero downtime.
- Valuation = AUD 10 million.
- Targeted purchase back premium = 25%
- Multiple media coverage and success case studies.
- Strong committed management team of advisors and board directors.
- Dividend payout of 20% per year from net profit.
- Remote medical consultation.
- Online prescription stream.
- Corporate wellness package.
- Telehealth tech for allied health providers.
- Telehealth for managed care operators.
- Virtual healthcare for the crisis.
- Cloud technologies.
- Virtual service platform.
- Strong network of affiliates and partners including AWS, Wolters Kluwer, Ndis, etc.
- The company is a tech-based solution provider in a remote environment.
- Employees work remotely and there is no office.
- The business is currently funded by MVP and Angel investors.
- Zero debt.
- Total number of shareholders: 20.
- Propotion of shares: Founder 50% and others 50%
-
Earlier than 15 daysFinance Director, Finance - IT, Adelaide, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysDirector, Healthcare - Pharma, Dubai, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysCEO, Biotechnology Research, Singapore, Individual Investor / Buyer connected with the Business